Anti-OCT-4 (POU5F1/OTF3) antibodies are used in immunohistochemistry to detect pluripotent germ cell markers in genitourinary pathology, supporting accurate identification of germ cell tumors. Their characteristic nuclear staining and validated diagnostic performance make them integral components of CE-IVD IHC panels in modern pathology workflows.
Biological Significance of OCT-4 (OTF3 / POU5F1)
OCT-4 is a POU-domain transcription factor essential for pluripotency regulation and early germline development.
- Maintains embryonic stem cell self-renewal and regulates differentiation pathways.
- Physiologically expressed in primordial germ cells and early embryonic tissues with limited somatic expression.
- Aberrant expression contributes to germ cell tumorigenesis by preserving an undifferentiated cellular phenotype.
Diagnostic Utility in Genitourinary Pathology
OCT-4 IHC is a validated biomarker for pluripotent germ cell tumors.
- Strong nuclear staining in seminoma, embryonal carcinoma, and germ cell neoplasia in situ (GCNIS) with high sensitivity and specificity.
- Helps differentiate OCT-4–positive tumors from yolk sac tumor and teratoma, which typically lack nuclear expression.
- Valuable in metastatic disease assessment and small biopsy samples due to clear nuclear signal.
Key Features of Anti-OCT-4 CE/IVD Antibodies (IHC)
Properties consistently described in peer-reviewed validation studies include:
- Predominant nuclear immunoreactivity consistent with transcription factor biology.
- High analytical sensitivity in formalin-fixed paraffin-embedded tissue sections used in routine diagnostics.
- Compatibility with automated IHC platforms and standardized CE-IVD workflows.
